News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
559,071 Results
Type
Article (37281)
Company Profile (218)
Press Release (521572)
Multimedia
Podcasts (75)
Webinars (10)
Section
Business (163940)
Career Advice (1202)
Deals (28826)
Drug Delivery (75)
Drug Development (61160)
Employer Resources (109)
FDA (14101)
Job Trends (11774)
News (271874)
Policy (23673)
Tag
Academia (2216)
Academic (1)
Accelerated approval (6)
Adcomms (13)
Allergies (61)
Alliances (45061)
ALS (80)
Alzheimer's disease (1083)
Antibody-drug conjugate (ADC) (112)
Approvals (14109)
Artificial intelligence (289)
Autoimmune disease (19)
Automation (17)
Bankruptcy (217)
Best Places to Work (9694)
BIOSECURE Act (13)
Biosimilars (70)
Biotechnology (169)
Bladder cancer (66)
Brain cancer (21)
Breast cancer (229)
Cancer (2001)
Cardiovascular disease (155)
Career advice (1016)
Career pathing (16)
CAR-T (144)
Cell therapy (420)
Cervical cancer (16)
Clinical research (49240)
Collaboration (825)
Compensation (261)
Complete response letters (16)
COVID-19 (2066)
CRISPR (50)
C-suite (220)
Cystic fibrosis (99)
Data (2016)
Decentralized trials (1)
Denatured (25)
Depression (40)
Diabetes (207)
Diagnostics (6107)
Digital health (19)
Diversity (4)
Diversity, equity & inclusion (31)
Drug discovery (121)
Drug pricing (53)
Drug shortages (14)
Duchenne muscular dystrophy (99)
Earnings (64326)
Editorial (29)
Employer branding (17)
Employer resources (98)
Events (79774)
Executive appointments (633)
FDA (15303)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (707)
Gene editing (125)
Generative AI (27)
Gene therapy (363)
GLP-1 (499)
Government (2792)
Grass and pollen (3)
Guidances (146)
Healthcare (15282)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (93)
Indications (21)
Infectious disease (2189)
Inflammatory bowel disease (121)
Inflation Reduction Act (6)
Influenza (47)
Intellectual property (90)
Interviews (193)
IPO (13221)
IRA (17)
Job creations (2528)
Job search strategy (878)
Kidney cancer (9)
Labor market (19)
Layoffs (353)
Leadership (10)
Legal (5613)
Liver cancer (68)
Lung cancer (281)
Lymphoma (131)
Machine learning (7)
Management (30)
Manufacturing (273)
MASH (53)
Medical device (12631)
Medtech (12636)
Mergers & acquisitions (16146)
Metabolic disorders (526)
Multiple sclerosis (67)
NASH (12)
Neurodegenerative disease (81)
Neuropsychiatric disorders (15)
Neuroscience (1552)
NextGen: Class of 2025 (5065)
Non-profit (3129)
Now hiring (16)
Obesity (270)
Opinion (196)
Ovarian cancer (66)
Pain (83)
Pancreatic cancer (72)
Parkinson's disease (124)
Partnered (18)
Patents (220)
Patient recruitment (96)
Peanut (31)
People (46739)
Pharmaceutical (37)
Pharmacy benefit managers (13)
Phase I (16391)
Phase II (21740)
Phase III (15942)
Pipeline (1255)
Policy (88)
Postmarket research (1564)
Preclinical (7077)
Press Release (72)
Prostate cancer (88)
Psychedelics (20)
Radiopharmaceuticals (246)
Rare diseases (380)
Real estate (4603)
Recruiting (45)
Regulatory (16965)
Reports (25)
Research institute (2094)
Resumes & cover letters (199)
Rett syndrome (6)
RNA editing (5)
RSV (35)
Schizophrenia (60)
Series A (128)
Series B (77)
Service/supplier (10)
Sickle cell disease (58)
Special edition (9)
Spinal muscular atrophy (156)
Sponsored (28)
Startups (3233)
State (2)
Stomach cancer (10)
Supply chain (45)
Tariffs (24)
The Weekly (48)
Vaccines (579)
Venture capitalists (28)
Weight loss (157)
Women's health (24)
Worklife (6)
Date
Today (53)
Last 7 days (843)
Last 30 days (2542)
Last 365 days (27441)
2025 (9918)
2024 (29964)
2023 (34116)
2022 (44750)
2021 (47953)
2020 (45314)
2019 (37861)
2018 (28697)
2017 (27787)
2016 (26370)
2015 (30831)
2014 (23123)
2013 (25301)
2012 (20571)
2011 (21003)
2010 (19130)
Location
Africa (604)
Alabama (47)
Alaska (6)
Arizona (157)
Arkansas (12)
Asia (39297)
Australia (6385)
California (5175)
Canada (1755)
China (474)
Colorado (244)
Connecticut (238)
Delaware (120)
Europe (78229)
Florida (795)
Georgia (181)
Idaho (47)
Illinois (424)
India (26)
Indiana (280)
Iowa (8)
Japan (168)
Kansas (95)
Kentucky (23)
Louisiana (9)
Maine (49)
Maryland (760)
Massachusetts (3916)
Michigan (211)
Minnesota (332)
Mississippi (2)
Missouri (78)
Montana (26)
Nebraska (19)
Nevada (58)
New Hampshire (67)
New Jersey (1527)
New Mexico (23)
New York (1442)
North Carolina (787)
North Dakota (9)
Northern California (2238)
Ohio (177)
Oklahoma (11)
Oregon (25)
Pennsylvania (1136)
Puerto Rico (14)
Rhode Island (30)
South America (850)
South Carolina (25)
South Dakota (1)
Southern California (1971)
Tennessee (81)
Texas (789)
United States (19684)
Utah (169)
Virginia (124)
Washington D.C. (37)
Washington State (500)
West Virginia (3)
Wisconsin (51)
559,071 Results for "gene technologies ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene therapy
Vertex Abandons AAV as Gene Therapy Space Weathers Difficulties
The cell and gene therapy space in recent months has hit several speedbumps, including layoffs, dropped drugs and discontinued partnerships.
May 5, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
CRISPR’s Casgevy on the Rise With More Gene Therapy Proof of Concept To Come in 2025
CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy Casgevy. While Vertex handles the market, CRISPR has been focused on its clinical program.
May 7, 2025
·
4 min read
·
Annalee Armstrong
FDA
Cell and Gene Therapy Sector Enters ‘Critical’ Period After Marks’ FDA Exit
As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene therapy space, experts express wariness over the unknowns and optimism that Marks’ legacy will carry on.
April 28, 2025
·
7 min read
·
Heather McKenzie
Press Releases
Genprex Signs Exclusive License to Additional Gene Therapy Technology with UTHealth Houston for the Treatment of Glioblastoma
May 6, 2025
·
7 min read
In partnership with GenScript
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.
April 14, 2025
·
6 min read
·
BioSpace Insights
Layoffs
Tenaya Slashes a Third of Workforce To Fund Development of Cardio Gene Therapies
The layoffs will take place throughout 2025 and will mostly affect Tenaya’s research and manufacturing operations. The company is continuing to test its hypertrophic cardiomyopathy gene therapy.
April 1, 2025
·
2 min read
·
Tristan Manalac
OBiO Technology will showcase at American Society of Gene & Cell Therapy
OBiO Technology Corp., Ltd. will showcase at American Society of Gene & Cell Therapy in Maryland, USA from May 7th to 11th.
April 28, 2024
·
3 min read
Gene therapy
5 Cardio Gene Therapies on the Near Horizon
Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic for cardiovascular diseases including congestive heart failure, chronic refractory angina and cardiomyopathy.
January 13, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Adeno-associated Virus Gene Therapy Market Size to Reach USD 107.2 Billion by 2035, Impelled by Advancements in Personalized Medicine.
Adeno-associated Virus Gene Therapy Market Outlook 2025-2035:
February 17, 2025
·
11 min read
Press Releases
Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome
April 3, 2025
·
3 min read
1 of 55,908
Next
